Reach Us +44-7456026878
Is Breast Cancer Treatment in the End of Life Less Aggressive? | OMICS International | Abstract
ISSN: 2165-7386

Journal of Palliative Care & Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Is Breast Cancer Treatment in the End of Life Less Aggressive?

Nuno Guerra-Pereira1, Fábio Cassiano2, Patrícia Gandolfo1, Patricia Cortes1, Carlos Carvalho2and Sofia Braga3,4*

1Department of Medicine and Biomedical Sciences, University of Algarve, Faro, Portugal

2Oncology Unit, Hospital Fernando Fonseca, Amadora, Portugal

3Division of Medical Oncology, Portuguese Institute of Oncology, Lisbon, Portugal

4Jose of Mello health, Lisboa, Portugal

*Corresponding Author:
Sofia Braga
Jose of Mello health
Av. of 3 Forte, Ed Suecia 3
floor 2, 2790-073 Lisboa, Portugal
Tel: 351966722731
E-mail: [email protected]

Received date: June 17, 2014; Accepted date: October 25, 2014; Published date: November 2, 2014

Citation: Guerra-Pereira N, Cassiano F, Gandolfo P, Cortes P, Carvalho C et al. (2014) Is Breast Cancer Treatment in the End of Life Less Aggressive?. J Palliat Care Med 4:194. doi:10.4172/2165-7386.1000194

Copyright: © 2014 Guerra-Pereira N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


There is overuse of palliative systemic therapy in the end of life of breast cancer patients, but the growing awareness of this practice and the emphasis put in quality of end of life care might be shifting this practice. We hypothesized we could observe: more implementation of palliative strategies; less administration of palliative systemic anti-cancer therapy and decreased aggressiveness of cancer care in the end of life. We characterized the shifting trends in use of palliative chemotherapy administration and palliative care approaches in different institutions and times. We selected women that died of breast cancer during six years, from 2007 to 2012, and were treated in a central acute care general hospital and compared it with the breast cancer patients that died in 2003 and were treated in a large cancer center. We analyzed a total of 232 patients: the more recent group has 114 women and the initial cohort has 118. We used descriptive statistics to characterize chemotherapy in the end of life and use of palliative care resources. We showed increased: referral to palliative care inpatient and outpatient teams,referral to outpatient pain clinics,use of palliative radiotherapy and deaths at hospices instead of at acute care hospitals. Chemotherapy is still prolonged until the end of life, notwithstanding we showed a decrease in such practice. Other indicators of agressiveness, namely hospital admissions, have also shown a decrease. We showed there is more integration of multidisciplinary palliative care and less aggressiveness in the treatment of breast cancer patients, namely, decreased use of palliative anti-cancer treatment and decreased acute care hospital admissions. Nonetheless, systemic chemotherapy is still used until too late and the integration of oncology and palliative medicine in the care of breast cancer patients in the end of life is lacking.


Recommended Conferences

20th World Congress on Clinical Nursing and Practice

Milan, Italy

10th International conference on Palliative Care

Barcelona, Spain
Share This Page